IP Library Granted Patent US 8,133,496
Granted Patent B2
US 8,133,496 · App. 13/038,930 · Granted Mar 13, 2012

Compositions and methods for diagnosing and treating urinary tract infections

Assignee: The Regents of the University of Michigan
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,133,496
App. No.
13/038,930
Granted
Mar 13, 2012
Kind
B2
Abstract

The present invention relates to methods and compositions for treating urinary tract infections. In particular, the present invention relates to vaccines and immune modulators for treating urinary tract infections.

Claims (8)

1. An antigenic composition comprising a conjugate of at least a portion of one or more isolated antigens selected from the group consisting of Iha, IreA, IutA, c2482 and IroN, wherein said at least a portion of said antigen is conjugated to a carrier, and wherein said at least a portion of said antigen comprises an antigenic determinant of said antigen.

2. The composition of claim 1 , wherein said carrier is selected from the group consisting of cholera toxin, tetanus toxin and diphtheria toxin.

3. The composition of claim 1 , wherein said at least a portion comprises extracellular loop 7 of IroN or loop 6 of IutA.

4. A composition comprising at least a portion of one or more antigens selected from the group consisting of Iha, IreA, IutA, IroN and c2482, wherein said at least a portion of said antigen comprises an antigenic determinant of said antigen.

5. The composition of claim 4 , wherein said composition further comprises a sterile pharmaceutically acceptable carrier protein.

6. The composition of claim 4 , wherein said at least a portion comprises extracellular loop 7 of IroN or loop 6 of IutA.

7. A vaccine composition, comprising at least one antigen covalently bound to an carrier, wherein said at least one antigen comprises at least a portion of one or more antigens selected from a group consisting of Iha, IreA, IutA, c2482 and IroN, wherein said at least a portion of said antigen comprises an antigenic determinant of said antigen.

8. The vaccine composition of claim 7 , wherein said at least a portion comprises extracellular loop 7 of IroN or loop 6 of IutA.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 15, 2011
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025954/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2011
From: MOBLEY, HARRY L.T.
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 025903/0509 →
Continuity (3)
Division 12204966 · Sep 5, 2008
Provisional Application 60970661 · Sep 7, 2007
Related Publication 20110159028A1 · Jun 30, 2011